英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home | Aditum Bio | Translating Science, Benefiting Patients
    Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines
  • People | Aditum Bio | Biotechnology Assets to Benefit Patients
    Aditum Bio has brought together a renowned, highly credentialed leadership team with the vision, expertise, and ambition to deliver on the promise of our new model of biotech venture capital
  • Portfolio | Aditum Bio | Biotechnology Assets to Benefit Patients
    Aditum Bio is harnessing our unique investment approach focused on the translational stage of drug development, combined with our agile operating model for company formation and trial execution, Aditum Bio has launched seven companies to date
  • Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to . . .
    Aditum Bio will provide funding for Kalexo Bio, and the parties will collaborate to advance 2MW7141 into clinical development Kalexo Bio was founded by Aditum Bio, whose mission is to develop therapies for patients in areas of high unmet need
  • About | Aditum Bio | Biotechnology Assets to Benefit Patients
    Aditum Bio brings together unmatched scientific and domain expertise with agile operational capabilities Our unique investment and operating model enables rapid company formation, planning, and execution to advance novel drug candidates into the clinic and speed their delivery to the patients who need them
  • News | Aditum Bio
    ‘Stealth’ VC firm Aditum Bio launches its second biotech startup PRESS RELEASE NOV 7, 2024 Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders IN THE NEWS AUG 14, 2023 Lilly Completes Acquisition of Versanis Bio for $1 925 Billion
  • Careers | Aditum Bio | Biotechnology Assets to Benefit Patients
    At Aditum Bio, we’re bringing fresh ideas and new approaches to biotech venture capital We are champions of science with a clear vision for translating its bold potential into the innovative medicines that help people live healthier lives
  • Values | Aditum Bio | Biotechnology Assets to Benefit Patients
    Aditum Bio is a new breed of biotech investment firm that is driven to translate science into the new medicines that make a meaningful difference in the lives of patients We are a dedicated and ambitious team that is tightly aligned by a set of core values that underscore the important work we do
  • Approach | Aditum Bio | Biotechnology Assets to Benefit Patients
    Aditum Bio stands apart in the biotech venture capital arena through our differentiated approach for identifying promising, clinic-ready therapies that offer value for underserved patient populations, in areas such as obesity, depression, substance abuse, renal disease, and infectious diseases
  • Biotechnology Assets to Benefit Patients - Aditum Bio
    Contact Aditum Bio for general inquiries TRANSLATING SCIENCE TO IMPROVE PATIENTS’ LIVES Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines





中文字典-英文字典  2005-2009